TABLE 5.
Sp. | DS | CA | RA | Sal B | Sal A | DT-1 | TS-1 | CT | TS-IIA | TP | TTS |
GLF | 0.62 ± 0.05 | 0.24 ± 0.06 | 19.12 ± 5.32* | 205.85 ± 46.04** | 2.03 ± 0.69** | 0.21 ± 0.12 | 0.039 ± 0.013 | 3.97 ± 2.96 | 2.67 ± 1.56 | 227.86 ± 51.93** | 6.89 ± 4.65 |
GLT | 0.35 ± 0.2 | 0.23 ± 0.03 | 9.2 ± 3.99 | 105.15 ± 56.73 | 1.16 ± 0.66 | 0.31 ± 0.04 | 0.024 ± 0.015 | 4.43 ± 1.09 | 1.99 ± 0.28 | 116.08 ± 61.43 | 6.75 ± 1.36 |
SEC | 0.72 ± 0.24* | 0.22 ± 0.05 | 16.38 ± 2.31 | 192.05 ± 23.63* | 1.74 ± 0.23* | 0.2 ± 0.13 | 0.043 ± 0.039 | 6.48 ± 8.43 | 3.52 ± 3.89 | 211.12 ± 21.69* | 10.25 ± 12.45 |
FUG | 0.3 ± 0.08 | 0.37 ± 0.17 | 5.86 ± 3.11 | 107.2 ± 41.38 | 0.79 ± 0.53 | 0.34 ± 0.03 | 0.065 ± 0.021 | 7.73 ± 0.73 | 5.89 ± 2.49 | 114.53 ± 44.86 | 14.02 ± 2.76 |
RHM | 0.37 ± 0.09 | 0.19 ± 0.01 | 16.21 ± 3.73 | 190.31 ± 32.7* | 1.62 ± 0.36 | 0.16 ± 0.04 | 0.038 ± 0.002 | 2.54 ± 0.64 | 2.02 ± 0.49 | 208.7 ± 36.83* | 4.76 ± 1.08 |
AMG | 0.49 ± 0.16 | 0.19 ± 0.04 | 11.67 ± 1.13 | 181.35 ± 43.01* | 1.44 ± 0.2 | 0.15 ± 0.01 | 0.032 ± 0.01 | 3.91 ± 1.94 | 2.73 ± 1.54 | 195.14 ± 42.89* | 6.83 ± 3.47 |
ACL | 0.24 ± 0.1 | 0.12 ± 0.01 | 8.29 ± 3.3 | 72.07 ± 35.47 | 0.76 ± 0.36 | 0.1 ± 0.04 | 0.023 ± 0.013 | 1.2 ± 0.46 | 0.74 ± 0.38 | 81.49 ± 39.05 | 2.06 ± 0.88 |
ACT | 0.46 ± 0.13 | 0.12 ± 0.03 | 14.38 ± 3.26 | 157.57 ± 22.94 | 1.86 ± 0.27* | 0.32 ± 0.21 | 0.061 ± 0.027 | 6.34 ± 3.09 | 3.4 ± 1.45 | 174.38 ± 26.54 | 10.12 ± 4.68 |
NM | 0.38 ± 0.14 | 0.12 ± 0.05 | 10.68 ± 5.2 | 100.06 ± 50.61 | 0.97 ± 0.39 | 0.15 ± 0.09 | 0.023 ± 0.019 | 3.62 ± 3.95 | 2.27 ± 3.01 | 112.22 ± 56.28 | 6.06 ± 7.03 |
*Means that there was a significant difference (p < 0.05) between the group compared with NM.
**Means that there was highly significant difference (p < 0.01) between the group compared with NM. Data are mean ± SD (n = 6).